EU to issue guidance on clinical trials in the autumn
This article was originally published in Clinica
Executive Summary
The Clinical Evaluations Task Force intends to issue in the autumn formal guidance for manufacturers on clinical trials. The guidance, known as a meddev (guidance endorsed by the European Commission), will clarify precisely what the manufacturers' obligations are in terms of using already existing clinical data and explain when manufacturers need to conduct full clinical trials. It will also explain the precise role of notified bodies, Steve Owen, head of European & Regulatory Affairs at the Medicines and Healthcare products Safety Agency told the 11th Annual ABHI Conference in London on June 17. The meeting was organised by IBC UK Conferences.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.